Read the online version
FOR AGENT/BROKER USE ONLY. DO NOT DISTRIBUTE.
AN IMPORTANT UPDATE FROM CIGNA
May Edition

Hello,

We are pleased to provide our integrated pharmacy clients and producers the latest information about our combination with Express Scripts.

This month we are excited to introduce inMyndSM, a new behavioral health solution, as well as an expanded Patient Assurance Program. You’ll also find a reminder about home delivery, 2020 formulary and biosimilar strategy updates, and a glimpse of what’s ahead.

This information will be sent to your Cigna Integrated Pharmacy clients in the next few days.


Latest News

inMynd – a new behavioral health solution included with integrated pharmacy benefits
Using integrated pharmacy insights, Cigna’s inMynd spans the spectrum of our customers’ mental health needs, identifies those patients at risk, and connects them with providers and behavioral health experts for improved outcomes and lower costs. inMynd is available at no additional cost to clients that have Cigna medical, behavioral and pharmacy benefits.

Learn more about inMynd

Patient Assurance Program expansion – lowers out-of-pocket drug cost
In 2019, we announced the Patient Assurance Program that caps the costs of certain insulins at $25 for a 30-day supply. Beginning in July 2020, the program will expand to include additional branded, non-insulin diabetes medications that help customers manage their blood sugar. The Patient Assurance Program is available at no additional cost as part of your clients’ integrated pharmacy benefits.

Learn more about our expanded Patient Assurance Program



Reminder

Encouraging home delivery as we shelter in place
During a time of social distancing, together let’s reinforce the importance of getting 90 days of medications sent right to employees’ homes, with free delivery.

  • We are encouraging clients to share this information with their employees.

Cigna's formulary and biosimilar strategy updates, July 2020
By regularly reviewing and updating our formularies, we are able to reduce drug spend and improve the health of our customers by acting on research findings gleaned from integrated benefits and new drugs to market such as biosimilars.

Learn more – formulary and biosimilar strategy updates


Coming Soon

In June, we will introduce how we are helping our integrated clients and customers manage the high costs of specialty drugs. Please watch your inbox for more information.


Please do not reply to this email. It is an unattended mailbox. If you have any questions regarding this communication, please contact your Cigna Client Manager.

Together, all the way.
All Cigna products and services are provided exclusively by or through operating subsidiaries of Cigna Corporation, including Cigna Health and Life Insurance Company (CHLIC), Cigna Behavioral Health, Inc., Express Scripts, Inc., or their affiliates.

948628 05/2020


Legal Disclaimer  |  Privacy  |  Product Disclosures  | Cigna Company Names

© 2020 Cigna. All rights reserved